{
    "nctId": "NCT01404377",
    "briefTitle": "Wound Infiltration and Breast Cancer Surgery",
    "officialTitle": "Double Blind Randomized Trial of Wound Infiltration With Ropivacaine After Breast Cancer Surgery",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "30% decrease in VAS score on mobilization on the day of surgery",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult ASA I - II patients, scheduled for unilateral mastectomy or tumorectomy associated with axillary lymph node dissection\n\nExclusion Criteria:\n\n* Patients receiving opioid or any other analgesic treatment for chronic pain before surgery, patients with known allergy to local anaesthetics, and patients with acquired or genetic haemostatic abnormality",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}